Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

REGistry of Long-term AnTithrombotic TherApy-1 — Stella

Home/Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))/REGistry of Long-term AnTithrombotic TherApy-1

View on ClinicalTrials.gov

Recruiting

Back to Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) trials

REGistry of Long-term AnTithrombotic TherApy-1

Trial locations(1 site)

Russia

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation, Moscow

Key details

Sponsor

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Enrollment target

~2,000 participants

Started

January 2015

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.